EP0324802A4 - Method for the treatment of body tissues and the administration of drugs thereto - Google Patents

Method for the treatment of body tissues and the administration of drugs thereto

Info

Publication number
EP0324802A4
EP0324802A4 EP19880903116 EP88903116A EP0324802A4 EP 0324802 A4 EP0324802 A4 EP 0324802A4 EP 19880903116 EP19880903116 EP 19880903116 EP 88903116 A EP88903116 A EP 88903116A EP 0324802 A4 EP0324802 A4 EP 0324802A4
Authority
EP
European Patent Office
Prior art keywords
drugs
administration
treatment
body tissues
tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880903116
Other versions
EP0324802A1 (en
Inventor
Edward S. Neiss
Charles G. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Publication of EP0324802A1 publication Critical patent/EP0324802A1/en
Publication of EP0324802A4 publication Critical patent/EP0324802A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19880903116 1986-09-19 1987-08-18 Method for the treatment of body tissues and the administration of drugs thereto Withdrawn EP0324802A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90983286A 1986-09-19 1986-09-19
US909832 1986-09-19

Publications (2)

Publication Number Publication Date
EP0324802A1 EP0324802A1 (en) 1989-07-26
EP0324802A4 true EP0324802A4 (en) 1991-07-24

Family

ID=25427897

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880903116 Withdrawn EP0324802A4 (en) 1986-09-19 1987-08-18 Method for the treatment of body tissues and the administration of drugs thereto

Country Status (4)

Country Link
EP (1) EP0324802A4 (en)
JP (1) JPH01503146A (en)
AU (1) AU2807689A (en)
WO (1) WO1989000848A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US5061688A (en) * 1988-08-19 1991-10-29 Illinois Institute Of Technology Hemoglobin multiple emulsion
DE4100059C2 (en) * 1991-01-03 1994-08-25 Adatomed Pharma & Med Treatment liquid for reapplication (detached) of detached retina to the choroid of the eye
US5200430A (en) * 1991-03-21 1993-04-06 Escalon Ophthalmics, Inc. Debridement of bodily cavities using debridement fluids
US5641509A (en) * 1992-06-26 1997-06-24 Lancaster Group Ag Preparation for topical use
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (en) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenic composition for topical use
DE4221268C2 (en) * 1992-06-26 1997-06-12 Lancaster Group Ag Use of a dermatological to support the oxygen transport in the skin
EP0692975A4 (en) * 1993-04-08 2000-11-29 Univ Queensland Administration of vaso-active agent and therapeutic agent
GB9308280D0 (en) * 1993-04-21 1993-06-02 Stead Gordon Thickening of fluorinated liquids
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
SG49032A1 (en) * 1993-11-15 1998-05-18 Baker Med Res Inst A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
DE4405627A1 (en) * 1994-02-22 1995-08-24 Hoechst Ag Oil emulsions containing fluorocarbons
EP2367531A4 (en) * 2008-11-25 2013-11-27 Oxygen Biotherapeutics Inc Perfluorocarbon gel formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE881267A (en) * 1980-01-18 1980-05-16 Stein Karl N METHOD FOR THE TREATMENT OF SKIN BURNS IN MAMMALS
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
EP0112658A2 (en) * 1982-11-26 1984-07-04 Children's Hospital Medical Center Extraocular device for treating the eye

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2743842C2 (en) * 1976-10-01 1982-07-01 Matsushita Electric Industrial Co., Ltd., Kadoma, Osaka Solid electrolytic capacitor and process for its manufacture

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
BE881267A (en) * 1980-01-18 1980-05-16 Stein Karl N METHOD FOR THE TREATMENT OF SKIN BURNS IN MAMMALS
EP0112658A2 (en) * 1982-11-26 1984-07-04 Children's Hospital Medical Center Extraocular device for treating the eye

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8900848A1 *

Also Published As

Publication number Publication date
JPH01503146A (en) 1989-10-26
EP0324802A1 (en) 1989-07-26
AU2807689A (en) 1989-03-01
WO1989000848A1 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
EG18268A (en) Medicament for the treatment of inflammation of the eye
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU4467589A (en) Treatment of skin diseases with artemisinin and derivatives
EP0292172A3 (en) Apparatus for thermal treatment of body tissue
AU4438589A (en) A method of and apparatus for the medical-therapeutic treatment of the human body
EP0378692A4 (en) Catheter for medical treatment
EP0388434A4 (en) Differential delivery of therapeutic agents across the blood brain barrier
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
AU2347888A (en) Method and apparatus for P-synchronously stimulating the heart of a patient
EP0506893A4 (en) Diagnosis and treatment of diseases
EP0270690A4 (en) Drug for treatment and prophylaxis of kidney and liver diseases.
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
YU95284A (en) Process for obtaining cosmetic agents for medical and normal body treatment
GB8428747D0 (en) Products for treatment of human body
EP0370115A4 (en) Catheter for diagnosis and therapy
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU6360486A (en) Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
GB8714972D0 (en) Medical treatment
EP0436717A4 (en) Method of treatment with medical agents
GB2220652B (en) Treatment of pastures
HK1005735A1 (en) Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
ZA881828B (en) Preparation for treatment of skin disorders
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880519

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NEISS, EDWARD S.

Inventor name: SMITH, CHARLES G.

A4 Supplementary search report drawn up and despatched

Effective date: 19910607

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19910823